The math
How impact compounds
Better rates for Canadians → more MBR revenue → more cancer research funding. Here's how the loop works at scale.
🇨🇦
Canadian saves more
Switches from 0.01% to 3.65%.
Earns $3,640/yr more per $100k.
Earns $3,640/yr more per $100k.
💼
MBR earns a referral
Small fee from the institution.
Standard industry practice.
Standard industry practice.
🔬
50% funds research
Half of MBR's net profit
goes to cancer research. Always.
goes to cancer research. Always.
Phase projections
These are honest estimates, not promises. Revenue depends on Canadians switching. The pledge percentage is fixed at 50%.
Phase A
Now → 2026
Now → 2026
Building the engine
Rate Intelligence Engine online. Benefit Snapshot live. First Canadians switching. First referral revenue generated.
~$0–$10k
research allocation
Phase B
2026–2027
2026–2027
WealthCare 50 Alliance launches
First corporate partners. Concierge service. Open Banking integration. Subscription revenue begins.
~$50–$250k
research allocation
Phase Z
2028+
2028+
Scale + exit
Major institution partnerships. Canadian Financial Health Index published annually. Exit event triggers lump-sum pledge.
$1M+
research allocation
Annual allocation record
Pre-revenue phase
MBR has not yet generated net profits. The first allocation will be published here once revenue begins. The pledge is irrevocable — this page will update.